Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Dec 8 (Reuters) - Recursion Pharma, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in ...

A woman’s story about being asked an unexpected question during a job interview has gone viral on social media, sparking discussion about honesty, self-awareness, and workplace values. The post, ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Wondering if Recursion Pharmaceuticals at around $4.83 is a beaten down bargain or a value trap? This breakdown walks through what the current market price is really implying. The stock has bounced ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

If you had a reputation for being a know-it-all as a kid, you’re likely now the person with a trusted list of trivia questions and answers on file. Not only that, but you probably love sentences that ...

If you have a Good Question you’d like us to try to answer, send it to goodquestion@wkyt.com. If you have a Good Question you’d like us to try to answer, send it ...

1. Would you rather be able to fly or be able to breathe underwater? 2. Would you rather your crush be able to read your mind or have access to your internet history? 3. Would you rather swim in the ...